Back to Search Start Over

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer.

Authors :
Candido Dos Reis FJ
Lynn S
Ali HR
Eccles D
Hanby A
Provenzano E
Caldas C
Howat WJ
McDuffus LA
Liu B
Daley F
Coulson P
Vyas RJ
Harris LM
Owens JM
Carton AF
McQuillan JP
Paterson AM
Hirji Z
Christie SK
Holmes AR
Schmidt MK
Garcia-Closas M
Easton DF
Bolla MK
Wang Q
Benitez J
Milne RL
Mannermaa A
Couch F
Devilee P
Tollenaar RA
Seynaeve C
Cox A
Cross SS
Blows FM
Sanders J
de Groot R
Figueroa J
Sherman M
Hooning M
Brenner H
Holleczek B
Stegmaier C
Lintott C
Pharoah PD
Source :
EBioMedicine [EBioMedicine] 2015 May 09; Vol. 2 (7), pp. 681-9. Date of Electronic Publication: 2015 May 09 (Print Publication: 2015).
Publication Year :
2015

Abstract

Background: Citizen science, scientific research conducted by non-specialists, has the potential to facilitate biomedical research using available large-scale data, however validating the results is challenging. The Cell Slider is a citizen science project that intends to share images from tumors with the general public, enabling them to score tumor markers independently through an internet-based interface.<br />Methods: From October 2012 to June 2014, 98,293 Citizen Scientists accessed the Cell Slider web page and scored 180,172 sub-images derived from images of 12,326 tissue microarray cores labeled for estrogen receptor (ER). We evaluated the accuracy of Citizen Scientist's ER classification, and the association between ER status and prognosis by comparing their test performance against trained pathologists.<br />Findings: The area under ROC curve was 0.95 (95% CI 0.94 to 0.96) for cancer cell identification and 0.97 (95% CI 0.96 to 0.97) for ER status. ER positive tumors scored by Citizen Scientists were associated with survival in a similar way to that scored by trained pathologists. Survival probability at 15 years were 0.78 (95% CI 0.76 to 0.80) for ER-positive and 0.72 (95% CI 0.68 to 0.77) for ER-negative tumors based on Citizen Scientists classification. Based on pathologist classification, survival probability was 0.79 (95% CI 0.77 to 0.81) for ER-positive and 0.71 (95% CI 0.67 to 0.74) for ER-negative tumors. The hazard ratio for death was 0.26 (95% CI 0.18 to 0.37) at diagnosis and became greater than one after 6.5 years of follow-up for ER scored by Citizen Scientists, and 0.24 (95% CI 0.18 to 0.33) at diagnosis increasing thereafter to one after 6.7 (95% CI 4.1 to 10.9) years of follow-up for ER scored by pathologists.<br />Interpretation: Crowdsourcing of the general public to classify cancer pathology data for research is viable, engages the public and provides accurate ER data. Crowdsourced classification of research data may offer a valid solution to problems of throughput requiring human input.

Details

Language :
English
ISSN :
2352-3964
Volume :
2
Issue :
7
Database :
MEDLINE
Journal :
EBioMedicine
Publication Type :
Academic Journal
Accession number :
26288840
Full Text :
https://doi.org/10.1016/j.ebiom.2015.05.009